kidney issues with tirzepatide GLP therapies have established themselves as kidney-protective in type 2 diabetes and high risk of disease. This new post-hoc analysis of SURPASS-CVOT's kidney outcomes shows greater kidney protection (#mounjaro) Positive Results for Tirzepatide in

Transparent pricing for life-changing medications.Semaglutide Annual Weight Loss ProgramsWhat's IncludedWeight loss medication (all doses) Syringes and alcohol swabs at no extra cost Virtual physician appointments as needed Shipping included Semaglutide PlusInjectable - $99/month $1,188 for 12-month supply All doses Learn MoreSubscribe Now!Tirzepatide Annual Weight Loss ProgramsWhat's IncludedWeight loss medication (all doses) Syringes and alcohol swabs

Licensed by the MHRA and prescribed off label to treat weight loss.

On GLP-1s

Learn what early research suggests about tolerance, cravings, and side-effect risks when mixing alcohol and Retatrutide.

Download this stock image: Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink)

Introduction There is widespread interest among patients, clinicians, regulators and other constituents in post-treatment patient-reported cancer data